Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock.

Bates ER, Stomel RJ, Hochman JS, Ohman EM.

Int J Cardiol. 1998 May 29;65 Suppl 1:S37-42. Review.

PMID:
9706825
2.

[Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].

Scholz KH.

Herz. 1999 Oct;24(6):448-64. Review. German.

PMID:
10546149
3.

Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K; IABP-SHOCK II Trial Investigators.

N Engl J Med. 2012 Oct 4;367(14):1287-96. doi: 10.1056/NEJMoa1208410. Epub 2012 Aug 26.

4.

Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era.

Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, Phillips HR 3rd, Califf RM.

J Am Coll Cardiol. 1992 Dec;20(7):1482-9.

5.
7.

[The use of intraaortic balloon counterpulsation in patients with acute myocardial infarction].

Gruzdev AK, Lazarev IA, Popova VV, Sal'nikov DV, Boshkov VB, Tiurina IuV, Sidorenko BA.

Kardiologiia. 2004;44(6):8-12. Russian.

PMID:
15211342
8.

Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis?

Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN.

Coron Artery Dis. 2008 Nov;19(7):521-6. doi: 10.1097/MCA.0b013e3283109011.

PMID:
18923249
9.

Management of cardiogenic shock complicating acute myocardial infarction: The Henry Ford Hospital experience and review of the literature.

Moosvi AR, Gheorghiade M, Goldstein S, Khaja F.

Henry Ford Hosp Med J. 1991;39(3-4):240-4. Review.

PMID:
1804830
10.

Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock.

Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ.

J Am Coll Cardiol. 1997 Jun;29(7):1454-8.

11.

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction.

Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S.

J Am Coll Cardiol. 1992 Apr;19(5):907-14.

12.

Intraaortic balloon pump support during high-risk coronary angioplasty.

Aguirre FV, Kern MJ, Bach R, Donohue T, Caracciolo E, Flynn MS, Wolford T.

Cardiology. 1994;84(3):175-86. Review.

PMID:
8205567
13.

Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM.

J Am Coll Cardiol. 1997 Sep;30(3):708-15.

14.

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH.

N Engl J Med. 1999 Aug 26;341(9):625-34.

15.

[Results of the use of intraaortic balloon counterpulsation in patients with perioperative myocardial infarct].

Nikiforov IuV, Eremenko AA.

Anesteziol Reanimatol. 1991 Jul-Aug;(4):16-9. Russian.

PMID:
1812867
16.

Cardiogenic shock complicating acute myocardial infarction--a review.

Dubey L, Sharma S, Gautam M, Gautam S, Guruprasad S, Subramanyam G.

Acta Cardiol. 2011 Dec;66(6):691-9. Review.

PMID:
22299378
17.

Cardiogenic shock: thrombolysis or angioplasty?

Chou TM, Amidon TM, Ports TA, Wolfe CL.

J Intensive Care Med. 1996 Jan-Feb;11(1):37-48. Review.

PMID:
10160069
18.

[Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].

Fornaro G, Prando MD, Parodi F, Cordero G, Sansa M, Bongo AS, Campi A, Aralda D, Dellavesa P, Aina F, Lazzero M, Cernigliaro C.

G Ital Cardiol. 1996 Dec;26(12):1385-99. Italian.

PMID:
9162668
19.

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U.

Am Heart J. 2012 Jun;163(6):938-45. doi: 10.1016/j.ahj.2012.03.012. Erratum in: Am Heart J. 2015 Jan;169(1):185.

PMID:
22709745
20.

The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.

Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM; Investigators in the National Registry of Myocardial Infarction 2.

Am Heart J. 2001 Jun;141(6):933-9.

PMID:
11376306

Supplemental Content

Support Center